You have no items in your shopping cart.
Search results for: 'recombinant'
SDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 17.1 KDa. Observed: 18-37 KDa, reducing conditions
Human
Ala18-Glu144
C-Avi-6His
20 μg, 100 μgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 24.3 KDa. Observed: 24-36 KDa, reducing conditions
Cynomolgus
Gln1-Ser218
C-6His
1 mg, 10 μg, 50 μg, 500 μgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 20.1 KDa. Observed: 22-36 KDa, reducing conditions
Cynomolgus
Ala46-Pro217
C-6His
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 28.5 KDa. Observed: 31-40 KDa, reducing conditions
Mouse
Gln24-Thr266
C-6His
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 27.3 KDa. Observed: 35-57 KDa, reducing conditions
Cynomolgus
Asp25-Asp259
C-6His
500 μg, 1 mg, 10 μg, 50 μgSDS-PAGE: Greater than 90% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 53.4 KDa. Observed: 70-110 KDa, reducing conditions
Cynomolgus
Asp25-Asp259
C-Fc
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 49.5 KDa. Observed: 55-100 KDa, reducing conditions
Human
His65-Ala265
N-Fc
10 μg, 50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 28 Kda. Observed: 33-45 KDa, reducing conditions
Cynomolgus
Ser25-Ser35
C-Fc
50 μg, 500 μg, 1 mg, 10 μgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 29.3 Kda. Observed: 35-50 KDa, reducing conditions
Mouse
Gly24-Ser47
C-Fc
50 μg, 500 μg, 1 mgSDS-PAGE: Greater than 95% as determined by reducing SDS-PAGE. (QC verified)
Predicted: 82.8 KDa. Observed: 95-133 KDa, reducing conditions
Cynomolgus
Trp28-Ala526
C-Fc
10 μg, 50 μg, 500 μg, 1 mg
